Perrigo exits dermacosmetics in €327m deal to sharpen self-care focus

Perrigo is selling its dermacosmetics branded business to KKR for up to €327 million, including €300 million upfront. The move aligns with Perrigo’s “Three-S” strategy to stabilise, streamline and strengthen operations by refocusing on core self-care categories with higher growth potential.

KKR will acquire brands such as ACO, Biodermal, Emolium and Iwostin, adding to its growing portfolio of health and beauty investments. Proceeds will go towards balance sheet improvements and strategic reinvestments.

The deal follows a string of Perrigo divestitures aimed at enhancing operational efficiency and market agility.See the full breakdown of the transaction here.